Kerry Fike, MD
RPh · DOUBLE BOARD-CERTIFIED · HARVARD MEDICAL SCHOOL
Double board certified in dermatology and micrographic dermatologic surgery (MDS). Harvard Medical School and Harvard Combined Dermatology trained.
Dr. Fike, a dermatologist who is double board certified in dermatology and micrographic dermatologic surgery (MDS), is a graduate of Harvard Medical School and the Harvard Combined Dermatology Residency Training Program. She achieved advanced training in Mohs surgery at the Florida State University College of Medicine Micrographic Surgery & Dermatologic Oncology Fellowship at Dermatology Associates of Tallahassee.
Specialties and clinical focus
Dr. Fike specializes in nonmelanoma skin cancer treatment and also participates in the treatment of dysplastic nevi and other benign skin growths that may require dermatologic surgery.
Where Dr. Fike trained and teaches
- Affiliate Staff Physician, Newton-Wellesley Hospital
- Fellow, American Academy of Dermatology
- Fellow, American Society for Dermatologic Surgery
- Fellow, American College of Mohs Surgery
Dr. Fike is a Fellow of the American College of Mohs Surgery — the gold-standard credential for skin cancer surgeons.
Double board certified in dermatology and micrographic dermatologic surgery (MDS), with advanced fellowship training at Florida State's Micrographic Surgery & Dermatologic Oncology program.
Specializes in nonmelanoma skin cancer treatment alongside the management of dysplastic nevi and other benign skin growths requiring dermatologic surgery.
10 Laurel Avenue
Wellesley, Massachusetts
Monday – Friday
8:30 a.m. – 5:00 p.m.
(781) 235-8155
Mention Dr. Fike when scheduling
Dr. Fike is blessed to have a wonderful husband and three teenage boys. She enjoys running with her Great Pyrenees.
We'd love to meet you
Request an appointment with Dr. Fike and our team will reach out within one business day.
See what our patients say online
Reviews from real patients across Wellesley, Newton, and the Greater Boston area — pulled directly from Google and other public sources.